Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$12.98
+2.28%
Mkt Cap $261.88M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+54.1%
Consensus $20.00 vs current $12.98
NASDAQ·Healthcare·Biotechnology
$12.98
+2.28%
Mkt Cap $261.88M
No recent rating data.
Price Target (6 analysts)
$20.00
Range $20.00 – $20.00
+54.1%
Consensus $20.00 vs current $12.98